These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 36884387)

  • 1. Erratum to "Targeting SARS-CoV-2 by synthetic dual-acting thiol compounds that inhibit Spike/ACE2 interaction and viral protein production".
    FASEB J; 2023 Apr; 37(4):e22850. PubMed ID: 36884387
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting SARS-CoV-2 by synthetic dual-acting thiol compounds that inhibit Spike/ACE2 interaction and viral protein production.
    Fraternale A; De Angelis M; De Santis R; Amatore D; Masini S; Monittola F; Menotta M; Biancucci F; Bartoccini F; Retini M; Fiori V; Fioravanti R; Magurano F; Chiarantini L; Lista F; Piersanti G; Palamara AT; Nencioni L; Magnani M; Crinelli R
    FASEB J; 2023 Feb; 37(2):e22741. PubMed ID: 36583713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peimine inhibits variants of SARS-CoV-2 cell entry via blocking the interaction between viral spike protein and ACE2.
    Wang WJ; Chen Y; Su WC; Liu YY; Shen WJ; Chang WC; Huang ST; Lin CW; Wang YC; Yang CS; Hou MH; Chou YC; Wu YC; Wang SC; Hung MC
    J Food Biochem; 2022 Oct; 46(10):e14354. PubMed ID: 35894128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin yolk targeting spike 1, receptor binding domain of spike glycoprotein and nucleocapsid of SARS-CoV-2 blocking RBD-ACE2 binding interaction.
    Eka Saputri M; Aisyah Rahmalia Effendi S; Nadila R; Azzam Fajar S; Damajanti Soejoedono R; Handharyani E; Nadia Poetri O
    Int Immunopharmacol; 2022 Nov; 112():109280. PubMed ID: 36183680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiol drugs decrease SARS-CoV-2 lung injury
    Khanna K; Raymond W; Jin J; Charbit AR; Gitlin I; Tang M; Werts AD; Barrett EG; Cox JM; Birch SM; Martinelli R; Sperber HS; Franz S; Pillai S; Healy AM; Duff T; Oscarson S; Hoffmann M; Pöhlmann S; Simmons G; Fahy JV
    bioRxiv; 2021 Nov; ():. PubMed ID: 33330868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor.
    Hati S; Bhattacharyya S
    ACS Omega; 2020 Jul; 5(26):16292-16298. PubMed ID: 32656452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
    Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor.
    Souza PFN; Lopes FES; Amaral JL; Freitas CDT; Oliveira JTA
    Int J Biol Macromol; 2020 Dec; 164():66-76. PubMed ID: 32693122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disulfiram blocked cell entry of SARS-CoV-2 via inhibiting the interaction of spike protein and ACE2.
    Chen HF; Hsueh PR; Liu YY; Chen Y; Chang SY; Wang WJ; Wu CS; Tsai YM; Liu YS; Su WC; Chou YC; Hung MC
    Am J Cancer Res; 2022; 12(7):3333-3346. PubMed ID: 35968340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Spike Glycoprotein and ACE2 Interaction Reveals Modulation of Viral Entry in Wild and Domestic Animals.
    Praharaj MR; Garg P; Kesarwani V; Topno NA; Khan RIN; Sharma S; Panigrahi M; Mishra BP; Mishra B; Kumar GS; Gandham RK; Singh RK; Majumdar S; Mohapatra T
    Front Med (Lausanne); 2021; 8():775572. PubMed ID: 35360445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peptide array pipeline for the development of Spike-ACE2 interaction inhibitors.
    Chopra A; Shukri AH; Adhikary H; Lukinović V; Hoekstra M; Cowpland M; Biggar KK
    Peptides; 2022 Dec; 158():170898. PubMed ID: 36279985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents.
    Mei J; Zhou Y; Yang X; Zhang F; Liu X; Yu B
    J Ethnopharmacol; 2021 Oct; 278():114303. PubMed ID: 34102269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Based Development of SARS-CoV-2 Spike Interactors.
    Squeglia F; Romano M; Esposito L; Barra G; Campiglia P; Sala M; Scala MC; Ruggiero A; Berisio R
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of Interaction between the Spike Protein of SARS-CoV-2 and ACE2-Expressing Cells Using an In Vitro Cell Capturing System.
    Shang Y; Chen F; Li S; Song L; Gao Y; Yu X; Zheng J
    Biol Proced Online; 2021 Aug; 23(1):16. PubMed ID: 34433426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eugenol, a Component of Holy Basil (Tulsi) and Common Spice Clove, Inhibits the Interaction Between SARS-CoV-2 Spike S1 and ACE2 to Induce Therapeutic Responses.
    Paidi RK; Jana M; Raha S; McKay M; Sheinin M; Mishra RK; Pahan K
    J Neuroimmune Pharmacol; 2021 Dec; 16(4):743-755. PubMed ID: 34677731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spike-ACE2 binding assay: An in vitro platform for evaluating vaccination efficacy and for screening SARS-CoV-2 inhibitors and neutralizing antibodies.
    Zhang S; Gao C; Das T; Luo S; Tang H; Yao X; Cho CY; Lv J; Maravillas K; Jones V; Chen X; Huang R
    J Immunol Methods; 2022 Apr; 503():113244. PubMed ID: 35218866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SpACE-CCM: A facile and versatile cell culture medium-based biosensor for detection of SARS-CoV-2 spike-ACE2 interaction.
    Ham Y; Cho NC; Kim D; Kim JH; Jo MJ; Jeong MS; Pak BY; Lee S; Lee MK; Chi SW; Kim TD; Jeong NC; Cho S
    Biosens Bioelectron; 2023 May; 227():115169. PubMed ID: 36827795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study.
    Farouk AE; Baig MH; Khan MI; Park T; Alotaibi SS; Dong JJ
    Saudi J Biol Sci; 2021 Jun; 28(6):3262-3269. PubMed ID: 33654454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk.
    Chen P; Wang J; Xu X; Li Y; Zhu Y; Li X; Li M; Hao P
    Comput Biol Chem; 2022 Feb; 96():107613. PubMed ID: 34896769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein.
    Hussain M; Jabeen N; Raza F; Shabbir S; Baig AA; Amanullah A; Aziz B
    J Med Virol; 2020 Sep; 92(9):1580-1586. PubMed ID: 32249956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.